Related references
Note: Only part of the references are listed.Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study
Louisa Maria Bulirsch et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2022)
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES A Review
Jeffrey S. Heier et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)
Sustained-release drug delivery systems for the treatment of glaucoma
Natasha P. Kesav et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2021)
DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
Roland Beckmann et al.
NATURE COMMUNICATIONS (2021)
Application of Deep Learning for Diagnosing, Classifying, and Treating Age-Related Macular Degeneration
Dan Gong et al.
SEMINARS IN OPHTHALMOLOGY (2021)
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab Post Hoc Review of HAWK and HARRIER
Jordi Mones et al.
OPHTHALMOLOGY (2021)
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Arshad M. Khanani et al.
OPHTHALMOLOGY RETINA (2021)
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment
Caroline R. Baumal et al.
OPHTHALMOLOGY RETINA (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach
Alfredo Garcia Layana et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Abicipar pegol: the non-monoclonal antibody anti-VEGF
Ashish Sharma et al.
EYE (2020)
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
Matus Rehak et al.
ACTA DIABETOLOGICA (2020)
Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Anthony P. Khawaja et al.
OPHTHALMOLOGY (2020)
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52-and 96-Week Findings from ALTAIR A Randomized Controlled Trial
Masahito Ohji et al.
ADVANCES IN THERAPY (2020)
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
E. Randy Craven et al.
DRUGS (2020)
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis Phase 3 Randomized Trial
Steven Yeh et al.
OPHTHALMOLOGY (2020)
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Hiroki Tsujinaka et al.
NATURE COMMUNICATIONS (2020)
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
Irene Tom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Optimizing DME Treatment With Decreased Injection Frequency Using Long-Term Steroid Implants
Dimosthenis Mantopoulos et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2020)
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2020)
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration 52-Week Results of Phase 3 Randomized Controlled Study
Derek Kunimoto et al.
OPHTHALMOLOGY (2020)
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Caroline R. Baumal et al.
OPHTHALMOLOGY (2020)
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration The AVENUE Phase 2 Randomized Clinical Trial
Jayashree Sahni et al.
JAMA OPHTHALMOLOGY (2020)
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration The STAIRWAY Phase 2 Randomized Clinical Trial
Arshad M. Khanani et al.
JAMA OPHTHALMOLOGY (2020)
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Felipe A. Medeiros et al.
OPHTHALMOLOGY (2020)
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study
Kun Liu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
Hamid Ahmadieh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gus Gazzard et al.
LANCET (2019)
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema BOULEVARD Phase 2 Randomized Trial
Jayashree Sahni et al.
OPHTHALMOLOGY (2019)
Intracerebral haemorrhage during alemtuzumab administration
Christina J. Azevedo et al.
LANCET NEUROLOGY (2019)
Innovative therapies for neovascular age-related macular degeneration
Hasenin Al-Khersan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Jiawen Xu et al.
JOURNAL OF CONTROLLED RELEASE (2019)
SALT Trial: Steroids after Laser Trabeculoplasty Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Sylvia L. Groth et al.
OPHTHALMOLOGY (2019)
Intravitreal Ziv-Aflibercept: A Comprehensive Review
Daniel Barmas-Alamdari et al.
SEMINARS IN OPHTHALMOLOGY (2019)
Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment Twelve-Month Results
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2019)
Netarsudil Ophthalmic Solution 0.02%: First Global Approval
Sheridan M. Hoy
DRUGS (2018)
Alemtuzumab-induced remission of multiple sclerosis-associated uveitis
Mark D. Willis et al.
INTERNATIONAL OPHTHALMOLOGY (2017)
Bioconjugate Therapeutics: Current Progress and Future Perspective
Feng Li et al.
MOLECULAR PHARMACEUTICS (2017)
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGICA (2017)
Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring
James D. Brandt et al.
OPHTHALMOLOGY (2017)
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Seth R. Flaxman et al.
LANCET GLOBAL HEALTH (2017)
An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications
Evan N. Dunn et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
Richard A. Lewis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy
Karin R. Pillunat et al.
ACTA OPHTHALMOLOGICA (2016)
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion 52-Week Results of the VIBRANT Study
W. Lloyd Clark et al.
OPHTHALMOLOGY (2016)
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
Sobha Sivaprasad et al.
CLINICAL OPHTHALMOLOGY (2016)
Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis
Scott M. Whitcup et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014 (2015)
Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants
Y. Yang et al.
EYE (2015)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Routine versus As-Needed Bevacizumab with 12-Weekly Assessment Intervals for Neovascular Age-Related Macular Degeneration 92-Week Results of the GMAN Trial
Sajjad Mahmood et al.
OPHTHALMOLOGY (2015)
Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
Karina Berg et al.
OPHTHALMOLOGY (2015)
Improved clinical control of a challenging case of Beh‡et's disease with rituximab therapy
Barbara Hong Zhao et al.
CLINICAL RHEUMATOLOGY (2014)
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis
Gilbert H. Daniels et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Experiences with Rituximab for the Treatment of Autoimmune Diseases with Ocular Involvement
Laura Pelegrin et al.
JOURNAL OF RHEUMATOLOGY (2014)
Treatment of retinal vasculitis in Behçet's disease with rituximab
Shahram Sadreddini et al.
Modern Rheumatology (2014)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Rituximab Therapy for Refractory Scleritis Results of a Phase I/II Dose-Ranging, Randomized, Clinical Trial
Eric B. Suhler et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion One-Year Results of the Phase 3 GALILEO Study
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
ONSET AND DURATION OF VISUAL ACUITY IMPROVEMENT AFTER DEXAMETHASONE INTRAVITREAL IMPLANT IN EYES WITH MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION
Baruch D. Kuppermann et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Rituximab Therapy for Refractory Orbital Inflammation Results of a Phase 1/2, Dose-Ranging, Randomized Clinical Trial
Eric B. Suhler et al.
JAMA OPHTHALMOLOGY (2014)
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops
Tina T. Wong et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study
David M. Brown et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Age-Related Macular Degeneration-Associated Silent Polymorphisms in HtrA1 Impair Its Ability To Antagonize Insulin-Like Growth Factor 1
Sarah Melissa P. Jacobo et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis
Susan Lightman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye
Samirkumar R. Patel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2011)
Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles
Samirkumar R. Patel et al.
PHARMACEUTICAL RESEARCH (2011)
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)
Fereydoun Davatchi et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)
Evaluation of an Intravitreal Fluocinolone Acetonide Implant versus Standard Systemic Therapy in Noninfectious Posterior Uveitis
Carlos Pavesio et al.
OPHTHALMOLOGY (2010)
Rituximab for treatment of ocular inflammatory disease: a series of four cases
P. A. Kurz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial
WG Hodge et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Share Paper
